DK0903150T3 - Regulering af immunoglobulinproduktion med interleukin-9 - Google Patents

Regulering af immunoglobulinproduktion med interleukin-9

Info

Publication number
DK0903150T3
DK0903150T3 DK98200841T DK98200841T DK0903150T3 DK 0903150 T3 DK0903150 T3 DK 0903150T3 DK 98200841 T DK98200841 T DK 98200841T DK 98200841 T DK98200841 T DK 98200841T DK 0903150 T3 DK0903150 T3 DK 0903150T3
Authority
DK
Denmark
Prior art keywords
interleukin
production
regulation
immunoglobulin production
ige
Prior art date
Application number
DK98200841T
Other languages
English (en)
Inventor
Bernard Dugas
Catherine Druez
Pierre Braquet
Catherine Uyttenhove
Snick Charles Van
Jean-Michel Mencia-Huerta
Jean-Christophe Renauld
Original Assignee
Ludwig Inst Cancer Res
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res, Sod Conseils Rech Applic filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of DK0903150T3 publication Critical patent/DK0903150T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2033—IL-5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
DK98200841T 1990-10-05 1991-10-01 Regulering af immunoglobulinproduktion med interleukin-9 DK0903150T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/593,238 US5132109A (en) 1990-10-05 1990-10-05 Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof

Publications (1)

Publication Number Publication Date
DK0903150T3 true DK0903150T3 (da) 2003-07-21

Family

ID=24373963

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98200841T DK0903150T3 (da) 1990-10-05 1991-10-01 Regulering af immunoglobulinproduktion med interleukin-9
DK91918691T DK0553198T3 (da) 1990-10-05 1991-10-01 Regulering af immunoglobulinproduktionen med interleukin-9

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91918691T DK0553198T3 (da) 1990-10-05 1991-10-01 Regulering af immunoglobulinproduktionen med interleukin-9

Country Status (11)

Country Link
US (1) US5132109A (da)
EP (2) EP0903150B1 (da)
JP (2) JP3205754B2 (da)
AT (2) ATE182079T1 (da)
AU (2) AU646509B2 (da)
CA (1) CA2093434C (da)
DE (2) DE69131450T2 (da)
DK (2) DK0903150T3 (da)
ES (2) ES2136065T3 (da)
GR (1) GR3031518T3 (da)
WO (1) WO1992005698A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU669889B2 (en) * 1992-03-09 1996-06-27 Ludwig Institute For Cancer Research Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
DE4322330A1 (de) 1992-08-31 1994-03-03 Behringwerke Ag Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
US6911887B1 (en) 1994-09-12 2005-06-28 Matsushita Electric Industrial Co., Ltd. Inductor and method for producing the same
US5908839A (en) * 1995-08-24 1999-06-01 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
AU2007202406B2 (en) * 1995-08-24 2010-08-12 Ligand Pharmaceuticals Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
DK1632248T3 (da) * 1995-08-24 2011-01-24 Ligand Pharm Inc Anti-interleukin-9-antistof eller anti-interleukin-9-receptor-antistof til behandling af bronkial overfølsomhed
US5830454A (en) * 1996-08-30 1998-11-03 Ludwig Institute For Cancer Research Method for treating cell mediated autoimmune disorders using interleukin-9
WO1998024904A2 (en) 1996-12-02 1998-06-11 Magainin Pharmaceuticals Inc. Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
CA2689842A1 (en) * 1996-12-02 1998-06-11 Genaera Corporation Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
ATE540695T1 (de) * 2001-06-08 2012-01-15 Genaera Corp Verfahren zur modulation von il-13
JP4270974B2 (ja) 2003-08-04 2009-06-03 本田技研工業株式会社 車両における燃料タンクの配置構造
US20100219541A1 (en) 2007-09-28 2010-09-02 Konica Minolta Opto, Inc. Method for manufacturing optical device
EP2266789A4 (en) 2008-03-19 2013-10-23 Konica Minolta Opto Inc PROCESS FOR PRODUCING MOLDED BODY OR THIN LENS
CN101970198B (zh) 2008-03-19 2013-05-29 柯尼卡美能达精密光学株式会社 晶片透镜的制造方法
WO2011136138A1 (ja) 2010-04-27 2011-11-03 コニカミノルタオプト株式会社 撮像用レンズ、ウエハレンズ、ウエハレンズ積層体、撮像用レンズの製造方法、撮像用レンズの中間物、撮像用レンズの中間物の製造方法
US9828087B2 (en) * 2016-01-27 2017-11-28 Honeywell International Inc. Systems and methods for ground effect ceiling limit display

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US511951A (en) * 1894-01-02 Chusetts
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US5013824A (en) * 1985-11-19 1991-05-07 Schering Corporation Human interleukin-4 peptides and conjugates thereof
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US4946945A (en) * 1987-06-23 1990-08-07 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
AU7552691A (en) * 1990-03-23 1991-10-21 GSF-Institut Fur Experimentalle Hamatologie Method for enhanced growth and proliferation of mast cells

Also Published As

Publication number Publication date
DE69133225T2 (de) 2004-02-19
CA2093434C (en) 1999-08-10
EP0553198A4 (en) 1994-08-17
JPH06502404A (ja) 1994-03-17
JP3205754B2 (ja) 2001-09-04
DK0553198T3 (da) 1999-12-27
EP0553198A1 (en) 1993-08-04
AU646509B2 (en) 1994-02-24
DE69133225D1 (de) 2003-04-24
ES2136065T3 (es) 1999-11-16
EP0903150B1 (en) 2003-03-19
ES2194273T3 (es) 2003-11-16
AU5243493A (en) 1994-02-17
DE69131450D1 (de) 1999-08-19
AU8760791A (en) 1992-04-28
CA2093434A1 (en) 1992-04-06
AU656493B2 (en) 1995-02-02
DE69131450T2 (de) 2000-03-30
ATE234632T1 (de) 2003-04-15
GR3031518T3 (en) 2000-01-31
EP0903150A1 (en) 1999-03-24
EP0553198B1 (en) 1999-07-14
JP2001253835A (ja) 2001-09-18
ATE182079T1 (de) 1999-07-15
US5132109A (en) 1992-07-21
WO1992005698A1 (en) 1992-04-16

Similar Documents

Publication Publication Date Title
DK0903150T3 (da) Regulering af immunoglobulinproduktion med interleukin-9
DE69528888T2 (de) Regulierung von nf-kappa-b aktivität durch proteasome
PL313260A1 (en) Monoclonal antibodies having properties making them able to cause apoptosis
SE9102074D0 (sv) Tomour antigen specific antibody
DE3684211D1 (da)
DK183590A (da) Fremgangsmaade til reduktion af immunoglobulin e-responser
ES537774A0 (es) Metodo de regular proporciones de combustible-aire en mezclas de combustible-aire
FI935408A (fi) Spaoraemnesrikt tillsatsmedel, foerfarande foer framstaellning daerav, preparat innehaollande detta och dess anvaendning
DK0553389T3 (da) Småkage med højt indhold af korn
NL940019I2 (nl) Remming van het infecterende karakter in vitro en het cytopatische effect van HTV-III/LAV door 2',3-didesoxycytidine.
DK154188D0 (da) Kraftanlaeg med forbraending i fluidiseret leje
DK0479884T3 (da) Kraftværk med fluid-bed forbrændingsreaktor
DE3862547D1 (de) Vorrichtung zur anaeroben behandlung von biomasse.
DK24891D0 (da) Monoklonalt antistof til inhibering af cellers infektion med hiv-vira
DK159141C (da) Fremgangsmaade til fremstilling af kautsjukmkaatter med mindst et yderligere lag kautsjuk i randzonen
DK157276C (da) Fremgangsmaade og anlaeg til stroemforsyning af vekselstroemsnet med en dieselmotor
ES536028A0 (es) Un procedimiento para producir interferon inmune humano recombinante intacto
ATE148163T1 (de) Monoklonale antikörper gegen leptosphaeria
FI862131A0 (fi) Menetelmä hybridoomasolulinjan ja sen tuottaman vasta-aineen tuottamiseksi
DK511479A (da) Regulering for koeremotor foedet af stroemretter i det svage feltomraade
FI924278A0 (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
IT1143000B (it) Metodo per ottimizzare la combustione di combustibili granulari o in piccolissimi pezzi e impianto per la sua realizzazione
SE8501740L (sv) Klammer med inverterat t-tversnitt
DK416480A (da) Kedel med fluidiseret forbraending og fremgangsmaade til regulering af forbraendingen